Suppr超能文献

肥胖糖尿病患者的体重减轻:二乙胺苯丙酮的双盲研究(作者译)

[Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)].

作者信息

Bratusch-Marrain P, Dudczak R, Waldhäusl W

出版信息

Wien Klin Wochenschr. 1979 Jun 22;91(13):455-8.

PMID:380178
Abstract

In a double-blind study 40 overweight maturity-onset diabetics on a weight-reducing diet were randomly assigned to treatment with either the appetite-suppressant diethylpropion hydrochloride (Tenuate), or placebo. After treatment for 8 weeks the mean weight loss achieved by each group was 4.9 and 3.3%, respectively. This approximately equal weight loss was too slight to exert any significant effect on glucose tolerance. Thus, an additional effect of this anorexiant in comparison with diet restriction alone, as described in obese non-diabetic subjects, is not evident in the case of obese diabetic patients.

摘要

在一项双盲研究中,40名采用减肥饮食的超重成年起病型糖尿病患者被随机分配接受食欲抑制剂盐酸二乙丙胺(Tenuate)或安慰剂治疗。治疗8周后,每组的平均体重减轻分别为4.9%和3.3%。这种大致相同的体重减轻幅度太小,无法对葡萄糖耐量产生任何显著影响。因此,与仅进行饮食限制相比,这种食欲抑制剂在肥胖非糖尿病患者中所描述的额外效果,在肥胖糖尿病患者中并不明显。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验